🔗 Share this article

An underground market for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of rapid UK delivery. Sellers market the substance there before directing customers to other platforms for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Experts Voice Worries

However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is worrisome and could result in users administering substances of unknown origin.

Several professionals stated the demand for retatrutide could be connected to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer laws, potentially leading to fines, prosecution or prison.

Service Response and Content Removal

According to TikTok, the platform has taken down violative material and prohibited related hashtags and query recommendations. The company stated it was committed to maintaining the service safe and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” instantly displays channels with numerous of users, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of entering one community, a seller shared contact information, where the majority of transactions take place. The seller sent an instruction manual and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, medical conditions or previous experience.

Product Information and Pricing

Within these groups, messages display black plastic parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When asked how much time a injector should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service said it regularly monitored harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously seen individuals harmed by personal administration from unconfirmed suppliers. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said the substance was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may expose users to potentially significant health risks”.